Tango Therapeutics (TNGX) Return on Sales: 2021-2025
Historic Return on Sales for Tango Therapeutics (TNGX) over the last 5 years, with Sep 2025 value amounting to -1.51%.
- Tango Therapeutics' Return on Sales rose 133.00% to -1.51% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.51%, marking a year-over-year increase of 133.00%. This contributed to the annual value of -3.10% for FY2024, which is 31.00% down from last year.
- According to the latest figures from Q3 2025, Tango Therapeutics' Return on Sales is -1.51%, which was up 74.77% from -5.99% recorded in Q2 2025.
- In the past 5 years, Tango Therapeutics' Return on Sales registered a high of -0.97% during Q3 2021, and its lowest value of -5.99% during Q2 2025.
- For the 3-year period, Tango Therapeutics' Return on Sales averaged around -3.23%, with its median value being -3.00% (2024).
- Its Return on Sales has fluctuated over the past 5 years, first surged by 157bps in 2023, then plummeted by 325bps in 2025.
- Tango Therapeutics' Return on Sales (Quarterly) stood at -1.57% in 2021, then crashed by 278bps to -4.35% in 2022, then soared by 157bps to -2.79% in 2023, then slumped by 31bps to -3.10% in 2024, then skyrocketed by 133bps to -1.51% in 2025.
- Its Return on Sales was -1.51% in Q3 2025, compared to -5.99% in Q2 2025 and -3.23% in Q1 2025.